Breaking News Instant updates and real-time market news.

BLRX

BioLineRx

$2.52 /

+0.03 (+1.20%)

07:07
01/22/20
01/22
07:07
01/22/20
07:07

BioLineRx completes patient recruitment in Phase 2a COMBAT/KEYNOTE-202 study

"We are pleased to see the triple combination arm of our Phase 2a pancreatic study advance according to plan," stated Philip Serlin, CEO of BioLineRx. "This follows very promising initial results that were presented last month at the ESMO IO conference, demonstrating robust and durable responses to the triple combination treatment. As previously stated, we remain on track to announce progression-free and overall survival data from the triple combination arm in mid-2020."

BLRX BioLineRx
$2.52 /

+0.03 (+1.20%)

05/14/19 H.C. Wainwright
BioLineRx has multiple catalysts coming in 2019, says H.C. Wainwright

TODAY'S FREE FLY STORIES

Earnings
Summit Hotel Properties sees FY20 AFFO $1.15-$1.27, consensus $1.27  16:38
02/25/20
02/25
16:38
02/25/20
16:38
INN

Summit Hotel Properties

$10.12 /

-0.64 (-5.95%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Toll Brothers reports Q1 EPS 41c, consensus 45c » 16:37
02/25/20
02/25
16:37
02/25/20
16:37
TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Summit Hotel Properties reports Q4 AFFO 26c, consensus 26c » 16:37
02/25/20
02/25
16:37
02/25/20
16:37
INN

Summit Hotel Properties

$10.12 /

-0.64 (-5.95%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Darling Ingredients reports Q4 adjusted EPS 92c, consensus 22c » 16:37
02/25/20
02/25
16:37
02/25/20
16:37
DAR

Darling Ingredients

$26.42 /

-1.21 (-4.38%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Disney CEO Iger says has 'absolute confidence' in next CEO Chapek » 16:37
02/25/20
02/25
16:37
02/25/20
16:37
DIS

Disney

$128.24 /

-4.79 (-3.60%)

Current Disney CEO Bob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
MicroVision reports preliminary Q4 revenue $4.6M, consensus $3.2M » 16:36
02/25/20
02/25
16:36
02/25/20
16:36
MVIS

MicroVision

$0.58 /

-0.0197 (-3.27%)

The company also…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Amarin sales force now doubled compared to 2019 » 16:36
02/25/20
02/25
16:36
02/25/20
16:36
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

Expansion of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RealReal sees FY20 Gross Merchandise Value of $1.315B-$1.345B » 16:35
02/25/20
02/25
16:35
02/25/20
16:35
REAL

RealReal

$14.99 /

+0.03 (+0.20%)

Sees FY20 expected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Amarin says normalized prescriptions for Vascepa increased 84%-85% in Q4 » 16:35
02/25/20
02/25
16:35
02/25/20
16:35
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

Amarin said normalized…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RealReal sees Q1 Gross Merchandise Value of $291M-$295M » 16:34
02/25/20
02/25
16:34
02/25/20
16:34
REAL

RealReal

$14.99 /

+0.03 (+0.20%)

Sees Q1 expected adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Delek Logistics reports Q4 EPS 52c, consensus 74c » 16:34
02/25/20
02/25
16:34
02/25/20
16:34
DKL

Delek Logistics

$26.90 /

-2.22 (-7.62%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Origin Agritech not in compliance letter with NASDAQ listing rules » 16:34
02/25/20
02/25
16:34
02/25/20
16:34
SEED

Origin Agritech

$6.15 /

-0.39 (-5.96%)

Origin Agritech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Caesars CEO says delivered 'solid operational performance' in Q4 » 16:34
02/25/20
02/25
16:34
02/25/20
16:34
CZR

Caesars

$13.33 /

-0.69 (-4.92%)

"Caesars…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Amarin 'remains engaged' in ongoing patent litigation with generics » 16:33
02/25/20
02/25
16:33
02/25/20
16:33
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

Amarin said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Qurate Retail reports Q4 adj. EPS 68c, consensus 66c » 16:33
02/25/20
02/25
16:33
02/25/20
16:33
QRTEA

Qurate Retail

$8.54 /

-0.52 (-5.74%)

Reports Q4 revenue $4.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RealReal reports Q4 EPS (17c), consensus (19c) » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
REAL

RealReal

$14.99 /

+0.03 (+0.20%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Caesars reports Q4 adjusted EBITDA increased 2.8% to $583M » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
CZR

Caesars

$13.33 /

-0.69 (-4.92%)

Q4 non-GAAP adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RLJ Lodging Trust sees FY20 adjusted FFO $1.62-$1.77, consensus $1.79 » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
RLJ

RLJ Lodging Trust

$14.66 /

-0.96 (-6.15%)

Sees FY20 CapEx…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Delek US raises quarterly dividend 3.3% to 31c per share » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
DK

Delek US

$25.20 /

-1.475 (-5.53%)

Delek US announced today…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Novavax announces NanoFlu data from mice study published » 16:32
02/25/20
02/25
16:32
02/25/20
16:32
NVAX

Novavax

$7.96 /

-0.21 (-2.57%)

Novavax announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Mallinckrodt clearing path for shares to be revalued, says Stifel » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
MNK

Mallinckrodt

$4.72 /

+0.52 (+12.38%)

Stifel analyst Annabel…

Stifel analyst Annabel Samimy says Mallinckrodt reined in its largest overhangs by announcing an agreement in principle on terms of a global settlement that would address all opioid-related claims for $1.6B in structured payments as well as a debt refinancing that would address its April 2020 debt obligation. The news addresses two out of three of the company's most pressing cash-calls, Samimy tells investors in a research note. Though it puts the Specialty Generics unit into Chapter 11 temporarily to manage liabilities, this is the beginning of Mallinckrodt "retaking control of its broader business and clearing a path for shares to be revalued," contends the analyst. Samimy believes the tentative plans and reduced uncertainty "go a long way toward refocusing on the value" of Mallinckrodt's portfolio. The analyst keeps a Hold rating on the shares with an $8 price target. Mallinckrodt closed Tuesday up 16% to $4.75.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RLJ Lodging Trust reports Q4 adjusted FFO 41c, consensus 46c » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
RLJ

RLJ Lodging Trust

$14.66 /

-0.96 (-6.15%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Turning Point Brands approves $50M share repurchase » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

The repurchase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Caesars reports Q4 EPS (45c), may not compare to consensus (11c) » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
CZR

Caesars

$13.33 /

-0.69 (-4.92%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vistra Energy increases dividend 8% to 13.5c » 16:31
02/25/20
02/25
16:31
02/25/20
16:31
VST

Vistra Energy

$22.13 /

-0.84 (-3.66%)

Vistra Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.